High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies - Sorbonne Université
Journal Articles Journal of Clinical Microbiology Year : 2020

High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies

Dates and versions

hal-03793429 , version 1 (01-10-2022)

Identifiers

Cite

Narjis Boukli, Melchior Le Mene, Aurélie Schnuriger, Nancy Stella Cuervo, Cécilia Laroche, et al.. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies. Journal of Clinical Microbiology, 2020, 58 (11), pp.e01352-20. ⟨10.1128/JCM.01352-20⟩. ⟨hal-03793429⟩
14 View
0 Download

Altmetric

Share

More